Sibrafiban: A Viewpoint by Frans J. Van de Werf

Author： Van de Werf F.J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.57, Iss.2, 1999-02, pp. : 231-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sibrafiban

By Dooley M.   Goa K.L.  

Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. : 225-230

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Viewpoint by J. Elia

By Elia J.  

Pediatric Drugs, Vol. 5, Iss. 6, 2003-01 ,pp. : 416-417

Adis International

Access to resources Recommend Favorite

Sunitinib: A Viewpoint by Robert J. Motzer

By Motzer Robert J.  

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2267-2268

Adis International

Access to resources Recommend Favorite

Tegafur/Uracil: A Viewpoint by J. Feliu

By Feliu J.  

Drugs & Aging, Vol. 18, Iss. 12, 2001-12 ,pp. : 949-950

Adis International

Access to resources Recommend Favorite

Eletriptan: A Viewpoint by Timothy J. Steiner

By Steiner T.J.  

CNS Drugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 334-335

Adis International

Access to resources Recommend Favorite